These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9249224)

  • 1. Prophylaxis of mycobacterial infection and acquired drug resistance.
    Böttger EC; Böttger O; Stichnoth DO
    J Antimicrob Chemother; 1997 Jul; 40(1):145-6. PubMed ID: 9249224
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative cultures and drug susceptibility testing of Mycobacterium avium clinical isolates before and during the antimicrobial therapy.
    Heifets LB
    Res Microbiol; 1994; 145(3):188-96. PubMed ID: 7809471
    [No Abstract]   [Full Text] [Related]  

  • 3. Rifabutin for MAC questioned.
    Posit Aware; 1995; ():6. PubMed ID: 11362571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of disseminated Mycobacterium avium complex infection with reduced dose clarithromycin in patients with advanced HIV disease.
    Hewitt RG; Papandonatos GD; Shelton MJ; Hsiao CB; Harmon BJ; Kaczmarek SR; Amsterdam D
    AIDS; 1999 Jul; 13(11):1367-72. PubMed ID: 10449290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clarithromycin prophylaxis for disseminated Mycobacterium avium complex infection--efficacy and acquired resistance.
    Shafran SD
    Clin Infect Dis; 1998 Oct; 27(4):813-5. PubMed ID: 9798038
    [No Abstract]   [Full Text] [Related]  

  • 6. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
    Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
    J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Talbot JA; Chomyc S; Davison E; Singer J; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG
    Clin Infect Dis; 1998 Dec; 27(6):1401-5. PubMed ID: 9868650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS.
    Cohn DL
    Drugs; 1997; 54 Suppl 2():8-15; discussion 28-9. PubMed ID: 9358195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis of Mycobacterium avium complex infections in AIDS.
    Klaus BD
    Nurse Pract; 1995 Jun; 20(6):80-1. PubMed ID: 7659325
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimycobacterial synergism of clarithromycin and rifabutin.
    Ghebremichael S; Svenson SB; Källenius G; Hoffner SE
    Scand J Infect Dis; 1996; 28(4):387-90. PubMed ID: 8893404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Against the proposition: all patients with advanced HIV disease should be offered rifabutin prophylaxis.
    Pozniak A; Nelson MR
    Genitourin Med; 1996 Aug; 72(4):269-71. PubMed ID: 8976832
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.
    Gordin FM; Sullam PM; Shafran SD; Cohn DL; Wynne B; Paxton L; Perry K; Horsburgh CR
    Clin Infect Dis; 1999 May; 28(5):1080-5. PubMed ID: 10452638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium avium disease: progress at last.
    Bates JH
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1737-8. PubMed ID: 8665029
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of rifabutin resistance with prophylaxis for disseminated Mycobacterium avium complex.
    Böttger EC; Wallace RJ
    Lancet; 1994 Nov; 344(8935):1506-7. PubMed ID: 7734014
    [No Abstract]   [Full Text] [Related]  

  • 15. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
    Havlir DV; Dubé MP; Sattler FR; Forthal DN; Kemper CA; Dunne MW; Parenti DM; Lavelle JP; White AC; Witt MD; Bozzette SA; McCutchan JA
    N Engl J Med; 1996 Aug; 335(6):392-8. PubMed ID: 8676932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.
    Pierce M; Crampton S; Henry D; Heifets L; LaMarca A; Montecalvo M; Wormser GP; Jablonowski H; Jemsek J; Cynamon M; Yangco BG; Notario G; Craft JC
    N Engl J Med; 1996 Aug; 335(6):384-91. PubMed ID: 8663871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current strategies for the prevention and treatment of disseminated Mycobacterium avium complex infection in patients with AIDS.
    Wright J
    Pharmacotherapy; 1998; 18(4):738-47. PubMed ID: 9692648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium avium intracellulare infection in patients with HIV or AIDS.
    Brettle RP
    J Antimicrob Chemother; 1997 Aug; 40(2):156-60. PubMed ID: 9301979
    [No Abstract]   [Full Text] [Related]  

  • 19. [Management of atypical Mycobacterium infections in AIDS-patients].
    Internist (Berl); 1996 Apr; 37(4 Suppl):1-8. PubMed ID: 9131082
    [No Abstract]   [Full Text] [Related]  

  • 20. MAC prophylaxis revisited.
    Torres G
    GMHC Treat Issues; 1996 Apr; 10(4):6-7, 10. PubMed ID: 11363706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.